Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-01 @ 3:09 AM
Study NCT ID:
NCT04727151
Status:
TERMINATED
Last Update Posted:
2025-06-08
First Post:
2021-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TAC T-cells for the Treatment of HER2-positive Solid Tumors
Sponsor:
Triumvira Immunologics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-25
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-20
First Submit QC Date:
None
Study First Post Date:
2021-01-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-19
Results First Submit QC Date:
None
Results First Post Date:
2025-06-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-05
Last Update Post Date:
2025-06-08
Last Update Post Date Type:
ACTUAL